Potential antiviral effects of pantethine against SARS-CoV-2

Potential antiviral effects of pantethine against SARS-CoV-2

Abstract SARS-CoV-2 interacts with cellular cholesterol during many stages of its replication cycle. Pantethine was reported to reduce total cholesterol levels and fatty acid synthesis and potentially alter different processes that might be involved in the SARS-CoV-2 replication cycle. Here, we expl...

Full description

Bibliographic Details
Main Authors:	M. Abou-Hamdan, R. Saleh, S. Mani, P. Dournaud, M. Metifiot, M. L. Blondot, M. L. Andreola, F. Abdel-sater, M. De Reggi, P. Gressens, M. Laforge
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-02-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-023-29245-0

Similar Items

Effect of pantethine on ovarian tumor progression and choline metabolism
by: Marie-France Penet, et al.
Published: (2016-11-01)

Enhancement of L-3-hydroxybutyryl-CoA dehydrogenase activity and circulating ketone body levels by pantethine. Relevance to dopaminergic injury
by: de Reggi Max, et al.
Published: (2010-04-01)

Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine.
by: Manuel van Gijsel-Bonnello, et al.
Published: (2017-01-01)

Correction: Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine.
by: Manuel van Gijsel-Bonnello, et al.
Published: (2018-01-01)

Natural Molecules and Neuroprotection: Kynurenic Acid, Pantethine and α-Lipoic Acid
by: Fanni Tóth, et al.
Published: (2021-01-01)

Pantethine inhibits cholesterol and fatty acid syntheses and stimulates carbon dioxide formation in isolated rat hepatocytes.
by: G Cighetti, et al.
Published: (1987-02-01)

Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV
by: Stacey L. P. Scroggs, et al.
Published: (2020-12-01)

Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2
by: Driouich, J-S, et al.
Published: (2022)

Development of SARS-CoV-2 entry antivirals
by: Meiyue Dong, et al.
Published: (2024-02-01)

Antiviral Activity of Zinc Oxide Nanoparticles against SARS-CoV-2
by: Stella Wolfgruber, et al.
Published: (2023-05-01)

In vitro antiviral effect of silver nanoparticles against SARS-CoV-2
by: Lizdany Flórez-Álvarez, et al.
Published: (2023-01-01)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
by: Hatem A. Elshabrawy
Published: (2020-06-01)

Noble Metal Organometallic Complexes Display Antiviral Activity against SARS-CoV-2
by: Christina Chuong, et al.
Published: (2021-05-01)

Phytochemicals as potential antiviral agents in SARS-CoV-2 therapy: an update
by: Nerilson M. Lima, et al.
Published: (2021-07-01)

Antiviral Effect of Budesonide against SARS-CoV-2
by: Natalie Heinen, et al.
Published: (2021-07-01)

SARS-CoV-2 RNA polymerase as target for antiviral therapy
by: Luigi Buonaguro, et al.
Published: (2020-05-01)

SARS-CoV-2 cell entry and targeted antiviral development
by: Zinuo Chen, et al.
Published: (2021-12-01)

Absence of Resistance Mutations in the Integrase Coding Region among ART-Experienced Patients in the Republic of the Congo
by: Ferdinand Emaniel Brel Got, et al.
Published: (2021-11-01)

Divergent trajectories of antiviral memory after SARS-CoV-2 infection
by: Tomic, A, et al.
Published: (2022)

Harnessing Antiviral Peptides as Means for SARS-CoV-2 Control
by: Khatereh Zarkesh, et al.
Published: (2023-06-01)

<i>In vitro</i> antiviral activity of VIFERON® rectal suppositories against SARS-CoV-2
by: I. N. Isakova-Sivak, et al.
Published: (2022-01-01)

A rational strategy for the maintenance of antiviral immunity to new SARS-CoV-2 strains
by: Vladimir P. Baklaushev, et al.
Published: (2022-10-01)

Pilot trial on the efficacy and safety of pantethine in children with pantothenate kinase-associated neurodegeneration: a single-arm, open-label study
by: Xuting Chang, et al.
Published: (2020-09-01)

Unveiling the Antiviral Capabilities of Targeting Human Dihydroorotate Dehydrogenase against SARS-CoV‑2
by: Aline D. Purificação, et al.
Published: (2024-02-01)

Antiviral Activity of Benzydamine Hydrochloride against SARS-CoV-2 in vitro Model
by: V. V. Lebedeva, et al.
Published: (2021-07-01)

Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2
by: Ahmed A. Al-Karmalawy, et al.
Published: (2021-10-01)

In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2
by: Mathieu Gendrot, et al.
Published: (2020-10-01)

Potential Antiviral Options against SARS-CoV-2 Infection
by: Aleksandr Ianevski, et al.
Published: (2020-06-01)

Lack of antiviral activity of darunavir against SARS-CoV-2
by: Sandra De Meyer, et al.
Published: (2020-08-01)

SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey
by: Abbas Hoballah, et al.
Published: (2022-01-01)

Curcumin Transferosome-Loaded Thermosensitive Intranasal in situ Gel as Prospective Antiviral Therapy for SARS-Cov-2
by: Eleraky NE, et al.
Published: (2023-10-01)

Enhanced In Vitro Antiviral Activity of Hydroxychloroquine Ionic Liquids against SARS-CoV-2
by: Francisco Faísca, et al.
Published: (2022-04-01)

EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2.
by: Wael H Roshdy, et al.
Published: (2020-01-01)

EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2
by: Wael H. Roshdy, et al.
Published: (2020-01-01)

Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2
by: Jean-Sélim Driouich, et al.
Published: (2022-08-01)

Antioxidants selenomethionine and D-pantethine differentially affect doxorubicin’s action on glutathione system in human leukemia cells varying in their resistance to chemotherapy in vitro
by: Yu. S. Kozak, et al.
Published: (2018-09-01)

Cu-based thin rolled foils: relationship among alloy composition, micromechanical and antiviral properties against SARS-CoV-2
by: L. Lorenzetti, et al.
Published: (2024-03-01)

Identification of the SARS-unique domain of SARS-CoV-2 as an antiviral target
by: Bo Qin, et al.
Published: (2023-07-01)

Clinical development of antivirals against SARS-CoV-2 and its variants
by: Qiaoshuai Lan, et al.
Published: (2024-01-01)

Mannose-Binding Lectins as Potent Antivirals against SARS-CoV-2
by: Victória Riquena Grosche, et al.
Published: (2023-09-01)